{"entity":{"type":"insider","cik":"0001615374","url":"/insider/0001615374","json_url":"/insider/0001615374.json","name":"OrbiMed Capital GP V LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":115,"n_filings":61,"first":"2014-08-06","last":"2026-04-09","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Capital GP V LLC","source":"filing","n_filings":61,"first_seen":"2014-08-06","last_seen":"2026-04-09"}],"transactions":[{"id":5901684,"accession":"0000947871-26-000421","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72939.0,"shares_display":"72,939","price_per_share":6.417444576975281,"price_display":"6.42","price_state":"stated","total_value":468081.99,"total_display":"468,081.99","total_whole":"468,082","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider","n_lines":2},{"id":5901680,"accession":"0000947871-26-000421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31719.0,"shares_display":"31,719","price_per_share":6.5186503357609,"price_display":"6.52","price_state":"stated","total_value":206765.07,"total_display":"206,765.07","total_whole":"206,765","shares_owned_after":34923.0,"shares_owned_after_display":"34,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider","n_lines":2},{"id":5190716,"accession":"0000947871-25-000927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000927","line_url":"/filing/0000947871-25-000927#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":1520000.0,"total_display":"1,520,000.00","total_whole":"1,520,000","shares_owned_after":4975291.0,"shares_owned_after_display":"4,975,291","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-23","filed_date":"2025-10-27","scope":"insider"},{"id":4523966,"accession":"0000947871-25-000898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000898","line_url":"/filing/0000947871-25-000898","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Capital GP V LLC; OrbiMed Israel GP II, L.P.; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000000.0,"shares_display":"5,000,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":4490254.0,"shares_owned_after_display":"4,490,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider","n_lines":2},{"id":4871445,"accession":"0000947871-25-000854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000854","line_url":"/filing/0000947871-25-000854#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","total_whole":"900,000","shares_owned_after":5975291.0,"shares_owned_after_display":"5,975,291","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-12","scope":"insider"},{"id":4871425,"accession":"0000947871-25-000636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000636","line_url":"/filing/0000947871-25-000636#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Corvus Pharmaceuticals, Inc.","issuer_ticker":"CRVS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1176332.0,"shares_display":"1,176,332","price_per_share":4.1586,"price_display":"4.16","price_state":"stated","total_value":4891894.2552,"total_display":"4,891,894.26","total_whole":"4,891,894","shares_owned_after":7165006.0,"shares_owned_after_display":"7,165,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider"},{"id":2340772,"accession":"0000950170-24-008053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-008053","line_url":"/filing/0000950170-24-008053","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Capital GP V LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP II, L.P.; OrbiMed Israel GP Ltd.","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3125000.0,"shares_display":"3,125,000","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","total_whole":"7,500,000","shares_owned_after":7526359.0,"shares_owned_after_display":"7,526,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-26","scope":"insider","n_lines":3},{"id":8192043,"accession":"0000947871-23-001104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-23-001104","line_url":"/filing/0000947871-23-001104#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87786.0,"shares_display":"87,786","price_per_share":2.23,"price_display":"2.23","price_state":"stated","total_value":195762.78,"total_display":"195,762.78","total_whole":"195,763","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-24","scope":"insider"},{"id":8620728,"accession":"0000947871-23-000713","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-23-000713","line_url":"/filing/0000947871-23-000713","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Israel GP II, L.P.; OrbiMed Israel BioFund GP Limited Partnership; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; Chimovits Erez; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Israel GP II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":875000.0,"shares_display":"875,000","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":1828750.0,"total_display":"1,828,750.00","total_whole":"1,828,750","shares_owned_after":5685259.0,"shares_owned_after_display":"5,685,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider","n_lines":4},{"id":6982408,"accession":"0000947871-22-001208","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-22-001208","line_url":"/filing/0000947871-22-001208#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3629226.0,"shares_display":"3,629,226","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":798429.72,"total_display":"798,429.72","total_whole":"798,430","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-11-25","scope":"insider"},{"id":6982405,"accession":"0000947871-22-001208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-22-001208","line_url":"/filing/0000947871-22-001208#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5617300.0,"shares_display":"5,617,300","price_per_share":0.21,"price_display":"0.21","price_state":"stated","total_value":1179633.0,"total_display":"1,179,633.00","total_whole":"1,179,633","shares_owned_after":3629226.0,"shares_owned_after_display":"3,629,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-25","scope":"insider"},{"id":6982401,"accession":"0000947871-22-001208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-001208","line_url":"/filing/0000947871-22-001208#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1034421.0,"shares_display":"1,034,421","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":227572.62,"total_display":"227,572.62","total_whole":"227,573","shares_owned_after":9246526.0,"shares_owned_after_display":"9,246,526","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-25","scope":"insider"},{"id":6348935,"accession":"0000947871-22-001164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-001164","line_url":"/filing/0000947871-22-001164#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":402000.0,"shares_display":"402,000","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":1290420.0,"total_display":"1,290,420.00","total_whole":"1,290,420","shares_owned_after":15219994.0,"shares_owned_after_display":"15,219,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-10","scope":"insider"},{"id":6320091,"accession":"0000947871-22-000675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-000675","line_url":"/filing/0000947871-22-000675#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26253.0,"shares_display":"26,253","price_per_share":15.93,"price_display":"15.93","price_state":"stated","total_value":418210.29,"total_display":"418,210.29","total_whole":"418,210","shares_owned_after":87786.0,"shares_owned_after_display":"87,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider"},{"id":6122308,"accession":"0000947871-22-000567","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-22-000567","line_url":"/filing/0000947871-22-000567#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30722.0,"shares_display":"30,722","price_per_share":2.49,"price_display":"2.49","price_state":"stated","total_value":76497.78,"total_display":"76,497.78","total_whole":"76,498","shares_owned_after":14817994.0,"shares_owned_after_display":"14,817,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-13","scope":"insider"},{"id":6122302,"accession":"0000947871-22-000567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-22-000567","line_url":"/filing/0000947871-22-000567#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":97094.0,"shares_display":"97,094","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":228170.9,"total_display":"228,170.90","total_whole":"228,171","shares_owned_after":14787272.0,"shares_owned_after_display":"14,787,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-13","scope":"insider"},{"id":6122299,"accession":"0000947871-22-000567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-000567","line_url":"/filing/0000947871-22-000567#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64700.0,"shares_display":"64,700","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":115813.0,"total_display":"115,813.00","total_whole":"115,813","shares_owned_after":14690178.0,"shares_owned_after_display":"14,690,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-13","scope":"insider"},{"id":6953008,"accession":"0000947871-22-000540","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-22-000540","line_url":"/filing/0000947871-22-000540#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24447.0,"shares_display":"24,447","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":39115.2,"total_display":"39,115.20","total_whole":"39,115","shares_owned_after":14625478.0,"shares_owned_after_display":"14,625,478","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-10","scope":"insider"},{"id":6953005,"accession":"0000947871-22-000540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-22-000540","line_url":"/filing/0000947871-22-000540#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90712.0,"shares_display":"90,712","price_per_share":1.56,"price_display":"1.56","price_state":"stated","total_value":141510.72,"total_display":"141,510.72","total_whole":"141,511","shares_owned_after":14601031.0,"shares_owned_after_display":"14,601,031","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-09","filed_date":"2022-05-10","scope":"insider"},{"id":6953002,"accession":"0000947871-22-000540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-000540","line_url":"/filing/0000947871-22-000540#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10200.0,"shares_display":"10,200","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":16626.0,"total_display":"16,626.00","total_whole":"16,626","shares_owned_after":14510319.0,"shares_owned_after_display":"14,510,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-06","filed_date":"2022-05-10","scope":"insider"},{"id":6365143,"accession":"0000947871-22-000429","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-22-000429","line_url":"/filing/0000947871-22-000429#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34500.0,"shares_display":"34,500","price_per_share":21.17,"price_display":"21.17","price_state":"stated","total_value":730365.0,"total_display":"730,365.00","total_whole":"730,365","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-03-31","scope":"insider"},{"id":6365142,"accession":"0000947871-22-000429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-22-000429","line_url":"/filing/0000947871-22-000429#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":22.39,"price_display":"22.39","price_state":"stated","total_value":1679250.0,"total_display":"1,679,250.00","total_whole":"1,679,250","shares_owned_after":34500.0,"shares_owned_after_display":"34,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-30","filed_date":"2022-03-31","scope":"insider"},{"id":6365141,"accession":"0000947871-22-000429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-000429","line_url":"/filing/0000947871-22-000429#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":365000.0,"shares_display":"365,000","price_per_share":21.52,"price_display":"21.52","price_state":"stated","total_value":7854800.0,"total_display":"7,854,800.00","total_whole":"7,854,800","shares_owned_after":109500.0,"shares_owned_after_display":"109,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"},{"id":4606483,"accession":"0000947871-21-001150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-21-001150","line_url":"/filing/0000947871-21-001150","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5357143.0,"shares_display":"5,357,143","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":18750000.5,"total_display":"18,750,000.50","total_whole":"18,750,001","shares_owned_after":3571428.0,"shares_owned_after_display":"3,571,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-08","scope":"insider","n_lines":2},{"id":4308483,"accession":"0000947871-21-001017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-21-001017","line_url":"/filing/0000947871-21-001017#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Corvus Pharmaceuticals, Inc.","issuer_ticker":"CRVS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1109644.0,"shares_display":"1,109,644","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":6757731.96,"total_display":"6,757,731.96","total_whole":"6,757,732","shares_owned_after":6943654.0,"shares_owned_after_display":"6,943,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"},{"id":5396494,"accession":"0000947871-21-000249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-21-000249","line_url":"/filing/0000947871-21-000249#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Corvus Pharmaceuticals, Inc.","issuer_ticker":"CRVS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1285714.0,"shares_display":"1,285,714","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":4499999.0,"total_display":"4,499,999.00","total_whole":"4,499,999","shares_owned_after":8053298.0,"shares_owned_after_display":"8,053,298","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"},{"id":2331455,"accession":"0000947871-20-000944","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-20-000944","line_url":"/filing/0000947871-20-000944#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21400.0,"shares_display":"21,400","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":41944.0,"total_display":"41,944.00","total_whole":"41,944","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-08","filed_date":"2020-12-10","scope":"insider"},{"id":3091400,"accession":"0001209191-20-052339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-052339","line_url":"/filing/0001209191-20-052339","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC; ORBIMED CAPITAL LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":950000.0,"shares_display":"950,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":17100000.0,"total_display":"17,100,000.00","total_whole":"17,100,000","shares_owned_after":475000.0,"shares_owned_after_display":"475,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-25","filed_date":"2020-09-29","scope":"insider","n_lines":2},{"id":2909475,"accession":"0000947871-20-000699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000699","line_url":"/filing/0000947871-20-000699#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43543.0,"shares_display":"43,543","price_per_share":108.54,"price_display":"108.54","price_state":"stated","total_value":4726157.22,"total_display":"4,726,157.22","total_whole":"4,726,157","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-19","scope":"insider"},{"id":2909472,"accession":"0000947871-20-000699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-20-000699","line_url":"/filing/0000947871-20-000699#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94900.0,"shares_display":"94,900","price_per_share":107.49,"price_display":"107.49","price_state":"stated","total_value":10200801.0,"total_display":"10,200,801.00","total_whole":"10,200,801","shares_owned_after":43543.0,"shares_owned_after_display":"43,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":3205006,"accession":"0000947871-20-000684","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-20-000684","line_url":"/filing/0000947871-20-000684#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20257.0,"shares_display":"20,257","price_per_share":109.03,"price_display":"109.03","price_state":"stated","total_value":2208620.71,"total_display":"2,208,620.71","total_whole":"2,208,621","shares_owned_after":138443.0,"shares_owned_after_display":"138,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-14","scope":"insider"},{"id":3205004,"accession":"0000947871-20-000684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000684","line_url":"/filing/0000947871-20-000684#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29251.0,"shares_display":"29,251","price_per_share":109.93,"price_display":"109.93","price_state":"stated","total_value":3215562.43,"total_display":"3,215,562.43","total_whole":"3,215,562","shares_owned_after":158500.0,"shares_owned_after_display":"158,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-14","scope":"insider"},{"id":3205000,"accession":"0000947871-20-000684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-20-000684","line_url":"/filing/0000947871-20-000684#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42679.0,"shares_display":"42,679","price_per_share":107.45,"price_display":"107.45","price_state":"stated","total_value":4585858.55,"total_display":"4,585,858.55","total_whole":"4,585,859","shares_owned_after":187751.0,"shares_owned_after_display":"187,751","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-08-14","scope":"insider"},{"id":2859455,"accession":"0000947871-20-000676","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-20-000676","line_url":"/filing/0000947871-20-000676#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39877.0,"shares_display":"39,877","price_per_share":105.78,"price_display":"105.78","price_state":"stated","total_value":4218189.06,"total_display":"4,218,189.06","total_whole":"4,218,189","shares_owned_after":230430.0,"shares_owned_after_display":"230,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-11","filed_date":"2020-08-11","scope":"insider"},{"id":2859450,"accession":"0000947871-20-000676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000676","line_url":"/filing/0000947871-20-000676#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47700.0,"shares_display":"47,700","price_per_share":105.23,"price_display":"105.23","price_state":"stated","total_value":5019471.0,"total_display":"5,019,471.00","total_whole":"5,019,471","shares_owned_after":270307.0,"shares_owned_after_display":"270,307","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-11","scope":"insider"},{"id":2859445,"accession":"0000947871-20-000676","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-20-000676","line_url":"/filing/0000947871-20-000676#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28993.0,"shares_display":"28,993","price_per_share":106.18,"price_display":"106.18","price_state":"stated","total_value":3078476.74,"total_display":"3,078,476.74","total_whole":"3,078,477","shares_owned_after":318007.0,"shares_owned_after_display":"318,007","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-11","scope":"insider"},{"id":3210329,"accession":"0001213900-20-015635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-20-015635","line_url":"/filing/0001213900-20-015635#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1455132.0,"shares_display":"1,455,132","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":7275660.0,"total_display":"7,275,660.00","total_whole":"7,275,660","shares_owned_after":12714404.0,"shares_owned_after_display":"12,714,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":2289798,"accession":"0000947871-20-000208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-20-000208","line_url":"/filing/0000947871-20-000208#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":83.52,"price_display":"83.52","price_state":"stated","total_value":41760000.0,"total_display":"41,760,000.00","total_whole":"41,760,000","shares_owned_after":347000.0,"shares_owned_after_display":"347,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-06","filed_date":"2020-03-10","scope":"insider"},{"id":2463933,"accession":"0000947871-20-000192","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-20-000192","line_url":"/filing/0000947871-20-000192#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":84.42,"price_display":"84.42","price_state":"stated","total_value":33768000.0,"total_display":"33,768,000.00","total_whole":"33,768,000","shares_owned_after":847000.0,"shares_owned_after_display":"847,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":2463928,"accession":"0000947871-20-000192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000192","line_url":"/filing/0000947871-20-000192#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":83.21,"price_display":"83.21","price_state":"stated","total_value":6240750.0,"total_display":"6,240,750.00","total_whole":"6,240,750","shares_owned_after":1272000.0,"shares_owned_after_display":"1,272,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"}],"collapsed":true,"next_cursor":"2020-03-03|2463928","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2023-06-29","last_seen":"2026-04-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2020-09-29","last_seen":"2025-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001626971","name":"Corvus Pharmaceuticals, Inc.","url":"/issuer/0001626971","role":"Director, Ten percent owner","n_filings":12,"first_seen":"2016-05-20","last_seen":"2025-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001595585","name":"Tricida, Inc.","url":"/issuer/0001595585","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2018-07-02","last_seen":"2022-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001738021","name":"Compass Therapeutics, Inc.","url":"/issuer/0001738021","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2020-06-23","last_seen":"2022-11-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001422142","name":"Aerpio Pharmaceuticals, Inc.","url":"/issuer/0001422142","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2017-03-17","last_seen":"2020-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001609550","name":"Inspire Medical Systems, Inc.","url":"/issuer/0001609550","role":"Director, Ten percent owner","n_filings":9,"first_seen":"2018-05-09","last_seen":"2020-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001459839","name":"SI-BONE, Inc.","url":"/issuer/0001459839","role":"Director","n_filings":1,"first_seen":"2018-10-19","last_seen":"2018-10-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001621227","name":"Adaptimmune Therapeutics PLC","url":"/issuer/0001621227","role":"Director","n_filings":6,"first_seen":"2016-05-25","last_seen":"2018-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2017-10-10","last_seen":"2018-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001581720","name":"Loxo Oncology, Inc.","url":"/issuer/0001581720","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2014-08-06","last_seen":"2017-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001636282","name":"Aeglea BioTherapeutics, Inc.","url":"/issuer/0001636282","role":"Ten percent owner","n_filings":1,"first_seen":"2017-02-21","last_seen":"2017-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Director","n_filings":1,"first_seen":"2016-05-13","last_seen":"2016-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001592288","name":"Dimension Therapeutics, Inc.","url":"/issuer/0001592288","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2015-10-29","last_seen":"2015-10-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001615374","retrieved_at":"2026-08-22T13:32:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}